Call 24/7:

1-800-818-4511

Ibogaine for Addiction

pexels johannes plenio 3421812

Patient Blood Report Before and After Ibogaine Treatment

 Ibogaine Treatment for alcohol and cocaine addiction

DATE:14.04.2021

AGE: 38 

GENDER: MALE         

WEIGHT BEFORE: 126.700 KG

WEIGHT AFTER: 121 KG  ALTURA/HIGH: 1.79

 

Treatment Duration and Dosage

The ibogaine treatment lasted over 10 days, with varying dosages administered daily. Booster doses were given on the first and second days. This blood report depicts the changes in various health parameters before and after a 10-day ibogaine treatment, highlighting significant improvements in certain areas.

1- Blood Pressure

The patient’s blood pressure readings demonstrated notable changes during the treatment. Starting at 103/63, there was a gradual increase to 133/88 by the last recorded day. While there was an increase, the readings remained within an acceptable range. This indicates that the ibogaine treatment did not significantly affect blood pressure and maintained overall stability.

 

2- Heart Rate

Heart rate fluctuations were observed throughout the treatment, starting at 87 bpm and reaching 77 bpm after a week. These fluctuations are relatively minor and do not suggest adverse effects on heart rate.

 

3- Glucose Levels

The patient’s glucose levels showed variations during treatment, with values fluctuating within a reasonable range. There was no significant increase or decrease in glucose levels, indicating that ibogaine did not adversely affect glucose metabolism.

 

4- SATO2

Oxygen saturation levels remained consistently within the healthy range, indicating that the patient maintained adequate oxygen levels in their blood throughout the treatment.

 

5- Cell Blood Count

The cell blood count indicated a minor decrease in lymphocytes and a slight increase in neutrophils post-treatment. These changes are relatively minor and do not raise significant concerns.

 

6- Biochemistry

Biochemical parameters showed a notable increase in ureic nitrogen and urea in serum levels. Creatinine levels are also increased. The report mentioned cocaine and alcohol use, which should be addressed for comprehensive care.

 

7- Lipid Profile

There were significant improvements in the lipid profile. Total cholesterol levels decreased from 143 mg/dL to 107 mg/dL, and LDL cholesterol levels reduced from 79.64 mg/dL to 61.68 mg/dL, indicating a positive effect on lipid metabolism. HDL cholesterol levels remained relatively stable.

 

8- Liver Function

Liver function markers, including AST, ALT, total bilirubin, indirect bilirubin, direct bilirubin, LDH, and GGT, all remained within normal ranges post-treatment, suggesting that ibogaine did not negatively impact liver function.

 

9- A1C Hemoglobin and C-Reactive Protein

A1C hemoglobin levels decreased slightly from 6.5% to 6.3%, indicating better long-term glucose control. C-reactive protein (CRP) levels slightly increased but remained relatively low, suggesting limited inflammation.

 

10- Hormone Levels

Total testosterone levels increased from 3.29 ng/mL to 6.1 ng/mL, signifying a significant improvement in hormonal balance.

 

11- Thyroid Function 

Thyroid function markers TSH and Free T4 displayed variations, with TSH decreasing and Free T4 increasing post-treatment. These changes may require further monitoring to assess their clinical significance.

 

12- Urine Drug Test

The urine drug test indicated the presence of cocaine (COC) before treatment, which became negative post-treatment. There was also the presence of benzodiazepines (BZD) post-treatment, suggesting the need for additional care regarding substance use.

 

Conclusion 

In summary, this blood report showcases the effects of a 10-day ibogaine treatment on various health parameters. While some fluctuations occurred, most parameters remained stable or improved, including blood pressure, lipid profile, and testosterone levels. The patient’s heart rate, glucose levels, and oxygen saturation remained within acceptable ranges. However, substance use, particularly cocaine and benzodiazepines, should be addressed as part of the patient’s comprehensive care plan. Further research and ongoing medical supervision are essential to understand better the long-term effects of ibogaine treatment on these parameters and the patient’s overall health.

 

 

Accessibility Toolbar